Walmart says baby formula availability improving in its stores [Financial Post (Toronto, Ontario, Canada)]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Financial Post
Advertisement The shortage, initially spurred by pandemic-induced supply chain issues, was exacerbated in February when Abbott Laboratories, the biggest U.S. supplier of baby formula, recalled some products and closed a manufacturing plant on reports of bacterial infections. In response to the shortage, U.S. health regulators have since relaxed import policies and shipped in millions of cans of emergency supplies from companies such as Nestle SA and Reckitt Benckiser. Abbott in early July resumed partial production of certain specialty and metabolic formulas at its Sturgis facility as well as imported baby formula products from its international plants to boost supplies. Walmart Chief Financial Officer John David Rainey said on an earnings call on Tuesday that the shortage of baby formula products the company experienced in a “big way” in the second quarter was improving. The retail bellwether also said it now expects a smaller drop in its annual profit forecast as discounts to c
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Drug Device Combination Products Market Worth Over $180 Billion by 2029 - Medtronic, Abbott Laboratories, and Boston Scientific Corporation Dominate the Industry [Yahoo! Finance]Yahoo! Finance
- R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO [Yahoo! Finance]Yahoo! Finance
- Pharmacogenomics Market Worth $19.5 billion by 2031 -- Exclusive Report by Meticulous Research® [Yahoo! Finance]Yahoo! Finance
- Drugmaker Abbott India posts Q4 profit rise on higher sales [Yahoo! Finance]Yahoo! Finance
- Drugmaker Abbott India posts Q4 profit rise on higher sales [Reuters]Reuters
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/10/24 - Form 144
- 5/8/24 - Form 4
- 5/7/24 - Form 144
- ABT's page on the SEC website